Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C

Purpose The aim of this study was to evaluate the efficacy of combining mitomycin-C (MMC) with modified rectangular 3-snip punctoplasty and mini-Monoka stent to treat punctal stenosis. Design This is a prospective interventional case series. Patients and methods The study included 62 eyes of 31 pati...

Full description

Bibliographic Details
Main Authors: Ahmed S Bayoumy, Taher K Eleiwa, Tarek Nehad, Mohamed N Elmohamady
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Delta Journal of Ophthalmology
Subjects:
Online Access:http://www.djo.eg.net/article.asp?issn=1110-9173;year=2021;volume=22;issue=1;spage=68;epage=72;aulast=Bayoumy
_version_ 1819291406534967296
author Ahmed S Bayoumy
Taher K Eleiwa
Tarek Nehad
Mohamed N Elmohamady
author_facet Ahmed S Bayoumy
Taher K Eleiwa
Tarek Nehad
Mohamed N Elmohamady
author_sort Ahmed S Bayoumy
collection DOAJ
description Purpose The aim of this study was to evaluate the efficacy of combining mitomycin-C (MMC) with modified rectangular 3-snip punctoplasty and mini-Monoka stent to treat punctal stenosis. Design This is a prospective interventional case series. Patients and methods The study included 62 eyes of 31 patients diagnosed with epiphora secondary to punctal stenosis who received modified rectangular 3-snip punctoplasty with mini-Monoka stent and MMC in their right eyes (Rt eye group) and modified rectangular 3-snip punctoplasty with mini-Monoka stent only in their left eyes (Lt eye group). Epiphora, punctal opening, and tear meniscus height (TMH) were evaluated and compared with the preoperative data in both groups. The main outcome measures were epiphora, punctal opening, and TMH. Results A total of 17 (54.8%) patients were females, with a mean age of 58.4±5.1 years. No surgical complications were reported. Epiphora and TMH were improved, with a functional success of 90.3% in the Rt eye group and 87.1% in the Lt eye group, as compared with the preoperative status (P<0.001). The punctum remained open, with anatomical success achieved in 29 (93.5%) eyes in the Rt eye group and in 28 (90.3%) eyes in the Lt eye group (P<0.03). Moreover, the TMH and punctal grading were significantly better in the Rt eye group compared with Lt eye group during the 12th and 24th postoperative week follow-up visits (P<0.05). Conclusion MMC proved to be an efficient and safe therapeutic adjuvant in the armamentarium of oculoplastic surgeons to treat punctal stenosis.
first_indexed 2024-12-24T03:38:08Z
format Article
id doaj.art-2443385df32248bfab05b69d591f62d2
institution Directory Open Access Journal
issn 1110-9173
2090-4835
language English
last_indexed 2024-12-24T03:38:08Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Delta Journal of Ophthalmology
spelling doaj.art-2443385df32248bfab05b69d591f62d22022-12-21T17:17:00ZengWolters Kluwer Medknow PublicationsDelta Journal of Ophthalmology1110-91732090-48352021-01-01221687210.4103/DJO.DJO_65_20Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-CAhmed S BayoumyTaher K EleiwaTarek NehadMohamed N ElmohamadyPurpose The aim of this study was to evaluate the efficacy of combining mitomycin-C (MMC) with modified rectangular 3-snip punctoplasty and mini-Monoka stent to treat punctal stenosis. Design This is a prospective interventional case series. Patients and methods The study included 62 eyes of 31 patients diagnosed with epiphora secondary to punctal stenosis who received modified rectangular 3-snip punctoplasty with mini-Monoka stent and MMC in their right eyes (Rt eye group) and modified rectangular 3-snip punctoplasty with mini-Monoka stent only in their left eyes (Lt eye group). Epiphora, punctal opening, and tear meniscus height (TMH) were evaluated and compared with the preoperative data in both groups. The main outcome measures were epiphora, punctal opening, and TMH. Results A total of 17 (54.8%) patients were females, with a mean age of 58.4±5.1 years. No surgical complications were reported. Epiphora and TMH were improved, with a functional success of 90.3% in the Rt eye group and 87.1% in the Lt eye group, as compared with the preoperative status (P<0.001). The punctum remained open, with anatomical success achieved in 29 (93.5%) eyes in the Rt eye group and in 28 (90.3%) eyes in the Lt eye group (P<0.03). Moreover, the TMH and punctal grading were significantly better in the Rt eye group compared with Lt eye group during the 12th and 24th postoperative week follow-up visits (P<0.05). Conclusion MMC proved to be an efficient and safe therapeutic adjuvant in the armamentarium of oculoplastic surgeons to treat punctal stenosis.http://www.djo.eg.net/article.asp?issn=1110-9173;year=2021;volume=22;issue=1;spage=68;epage=72;aulast=Bayoumymitomycin-cpunctal stenosispunctal stentpunctoplasty
spellingShingle Ahmed S Bayoumy
Taher K Eleiwa
Tarek Nehad
Mohamed N Elmohamady
Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C
Delta Journal of Ophthalmology
mitomycin-c
punctal stenosis
punctal stent
punctoplasty
title Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C
title_full Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C
title_fullStr Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C
title_full_unstemmed Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C
title_short Outcome of modified rectangular 3-snip punctoplasty with mini-Monoka stent and mitomycin-C
title_sort outcome of modified rectangular 3 snip punctoplasty with mini monoka stent and mitomycin c
topic mitomycin-c
punctal stenosis
punctal stent
punctoplasty
url http://www.djo.eg.net/article.asp?issn=1110-9173;year=2021;volume=22;issue=1;spage=68;epage=72;aulast=Bayoumy
work_keys_str_mv AT ahmedsbayoumy outcomeofmodifiedrectangular3snippunctoplastywithminimonokastentandmitomycinc
AT taherkeleiwa outcomeofmodifiedrectangular3snippunctoplastywithminimonokastentandmitomycinc
AT tareknehad outcomeofmodifiedrectangular3snippunctoplastywithminimonokastentandmitomycinc
AT mohamednelmohamady outcomeofmodifiedrectangular3snippunctoplastywithminimonokastentandmitomycinc